# Zoomcar Holdings, Inc.: financial statements, quarterly

ZCAR · OTC · CIK 1854275 · [Other](/sectors/other.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/zcar.md) · [Financials](/companies/zcar/financials.md) · [Filings](/companies/zcar/filings.md) · [Insiders](/companies/zcar/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/zcar/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2.7](/filings/0001213900-24-097455.md) | [2.4](/filings/0001213900-24-014163.md) | [2.2 d](/filings/0001213900-24-061273.md) | [2.2](/filings/0001213900-24-068999.md) | [2.2](/filings/0001213900-25-110391.md) | [2.4](/filings/0001213900-26-016885.md) | [2.2 d](/filings/0001213900-26-078693.md) | [2.3](/filings/0001213900-26-089946.md) | [2.3](/filings/0001213900-25-110391.md) | [2.4](/filings/0001213900-26-016885.md) | [2.2 d](/filings/0001213900-26-078693.md) | [2.4](/filings/0001213900-26-089946.md) |
| Cost of revenue | $m | [2.7](/filings/0001213900-24-097455.md) | [2.1](/filings/0001213900-25-014437.md) | [1.9 d](/filings/0001213900-25-059675.md) | [1.5](/filings/0001213900-25-076590.md) | [1.2](/filings/0001213900-25-110391.md) | [1.5](/filings/0001213900-26-016885.md) | [1.1 d](/filings/0001213900-26-078693.md) | [1.3](/filings/0001213900-26-089946.md) | [1.2](/filings/0001213900-25-110391.md) | [1.1](/filings/0001213900-26-016885.md) | [0.8 d](/filings/0001213900-26-078693.md) | [0.8](/filings/0001213900-26-089946.md) |
| Research and development | $m | [0.9](/filings/0001213900-24-097455.md) | [1.3](/filings/0001213900-25-014437.md) | [0.8 d](/filings/0001213900-25-059675.md) | [0.9](/filings/0001213900-25-076590.md) | [0.7](/filings/0001213900-25-110391.md) | [0.7](/filings/0001213900-26-016885.md) | [0.6 d](/filings/0001213900-26-078693.md) | [0.7](/filings/0001213900-26-089946.md) | [0.7](/filings/0001213900-25-110391.md) | [0.7](/filings/0001213900-26-016885.md) | [0.5 d](/filings/0001213900-26-078693.md) | [0.5](/filings/0001213900-26-089946.md) |
| Selling, general and administrative | $m | not reported | [9.8](/filings/0001213900-24-014163.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(4.3)](/filings/0001213900-24-097455.md) | [(11.7)](/filings/0001213900-25-014437.md) | [(8.2) d](/filings/0001213900-25-059675.md) | [(3.4)](/filings/0001213900-25-076590.md) | [(1.6)](/filings/0001213900-25-110391.md) | [(3.2)](/filings/0001213900-26-016885.md) | [(2.2) d](/filings/0001213900-26-078693.md) | [(1.8)](/filings/0001213900-26-089946.md) | [(2.0)](/filings/0001213900-25-110391.md) | [(1.5)](/filings/0001213900-26-016885.md) | [(1.6) d](/filings/0001213900-26-078693.md) | [(0.9)](/filings/0001213900-26-089946.md) |
| Interest expense | $m | [0.2](/filings/0001213900-24-097455.md) | [0.2](/filings/0001213900-25-014437.md) | not reported | not reported | [0.1](/filings/0001213900-24-097455.md) | [0.2](/filings/0001213900-25-014437.md) | not reported | [0.0](/filings/0001213900-25-076590.md) | [0.1](/filings/0001213900-25-110391.md) | [0.1](/filings/0001213900-26-016885.md) | not reported | not reported |
| Net income | $m | [(12.4)](/filings/0001213900-24-097455.md) | [14.4](/filings/0001213900-25-014437.md) | [(7.5) d](/filings/0001213900-25-059675.md) | [(2.5)](/filings/0001213900-26-016885.md) | [(3.4)](/filings/0001213900-26-016885.md) | [(7.9)](/filings/0001213900-26-016885.md) | [(11.8) d](/filings/0001213900-26-078693.md) | [(4.2)](/filings/0001213900-26-089946.md) | [(0.8)](/filings/0001213900-26-016885.md) | [(0.7)](/filings/0001213900-26-016885.md) | [(8.9) d](/filings/0001213900-26-078693.md) | [(5.4)](/filings/0001213900-26-089946.md) |
| Diluted EPS | $ per share | [(2568.82)](/filings/0001213900-24-097455.md) | [89.86](/filings/0001213900-25-014437.md) | not reported | [(73.90)](/filings/0001213900-25-076590.md) | [(88.56)](/filings/0001213900-25-110391.md) | [(71.26)](/filings/0001213900-26-016885.md) | not reported | [(0.50)](/filings/0001213900-26-089946.md) | [(0.07)](/filings/0001213900-25-110391.md) | [(0.06)](/filings/0001213900-26-016885.md) | not reported | [(0.24)](/filings/0001213900-26-089946.md) |
| Basic EPS | $ per share | [(2568.82)](/filings/0001213900-24-097455.md) | [451.45](/filings/0001213900-25-014437.md) | not reported | [(73.90)](/filings/0001213900-25-076590.md) | [(88.56)](/filings/0001213900-25-110391.md) | [(71.26)](/filings/0001213900-26-016885.md) | not reported | [(0.50)](/filings/0001213900-26-089946.md) | [(0.07)](/filings/0001213900-25-110391.md) | [(0.06)](/filings/0001213900-26-016885.md) | not reported | [(0.24)](/filings/0001213900-26-089946.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.8](/filings/0001213900-24-097455.md) | [6.1](/filings/0001213900-25-014437.md) | [1.5](/filings/0001213900-26-078693.md) | [1.6](/filings/0001213900-25-076590.md) | [0.6](/filings/0001213900-25-110391.md) | [4.4](/filings/0001213900-26-016885.md) | [1.1](/filings/0001213900-26-078693.md) | [0.4](/filings/0001213900-26-089946.md) | [0.2](/filings/0001213900-25-110391.md) | [0.2](/filings/0001213900-26-016885.md) | [0.3](/filings/0001213900-26-089946.md) | [0.4](/filings/0001213900-26-089946.md) |
| Current assets | $m | [0.1](/filings/0001410578-23-002528.md) | [9.6](/filings/0001213900-24-014163.md) | [5.1](/filings/0001213900-25-059675.md) | [4.3](/filings/0001213900-24-068999.md) | [2.6](/filings/0001213900-24-097455.md) | [6.0](/filings/0001213900-25-014437.md) | [3.0](/filings/0001213900-26-078693.md) | [1.7](/filings/0001213900-25-076590.md) | [1.1](/filings/0001213900-25-110391.md) | [0.9](/filings/0001213900-26-016885.md) | [1.3](/filings/0001213900-26-089946.md) | [1.3](/filings/0001213900-26-089946.md) |
| Total assets | $m | [30.8](/filings/0001410578-23-002528.md) | [16.8](/filings/0001213900-24-014163.md) | [9.2](/filings/0001213900-25-059675.md) | [8.0](/filings/0001213900-24-068999.md) | [6.2](/filings/0001213900-24-097455.md) | [9.5](/filings/0001213900-25-014437.md) | [5.4](/filings/0001213900-26-078693.md) | [3.9](/filings/0001213900-25-076590.md) | [3.1](/filings/0001213900-25-110391.md) | [2.8](/filings/0001213900-26-016885.md) | [3.2](/filings/0001213900-26-089946.md) | [3.2](/filings/0001213900-26-089946.md) |
| Current liabilities | $m | [11.1](/filings/0001410578-23-002528.md) | [25.7](/filings/0001213900-24-014163.md) | [31.3](/filings/0001213900-25-059675.md) | [38.1](/filings/0001213900-24-068999.md) | [37.7](/filings/0001213900-24-097455.md) | [46.8](/filings/0001213900-25-014437.md) | [29.5](/filings/0001213900-26-078693.md) | [29.5](/filings/0001213900-25-076590.md) | [29.7](/filings/0001213900-25-110391.md) | [29.2](/filings/0001213900-26-016885.md) | [37.5](/filings/0001213900-26-089946.md) | [38.0](/filings/0001213900-26-089946.md) |
| Total liabilities | $m | [23.2](/filings/0001410578-23-002528.md) | [43.1](/filings/0001213900-24-014163.md) | [42.9](/filings/0001213900-25-059675.md) | [39.5](/filings/0001213900-24-068999.md) | [38.9](/filings/0001213900-24-097455.md) | [48.0](/filings/0001213900-25-014437.md) | [30.7](/filings/0001213900-26-078693.md) | [30.7](/filings/0001213900-25-076590.md) | [30.8](/filings/0001213900-25-110391.md) | [30.2](/filings/0001213900-26-016885.md) | [38.5](/filings/0001213900-26-089946.md) | [38.9](/filings/0001213900-26-089946.md) |
| Long-term debt | $m | not reported | [4.4](/filings/0001213900-24-014163.md) | [2.9](/filings/0001213900-25-059675.md) | not reported | [3.7](/filings/0001213900-24-097455.md) | [3.0](/filings/0001213900-25-014437.md) | [2.5](/filings/0001213900-26-078693.md) | not reported | not reported | not reported | [2.1](/filings/0001213900-26-089946.md) | not reported |
| Current portion of debt | $m | not reported | [1.6](/filings/0001213900-24-014163.md) | [5.0](/filings/0001213900-25-059675.md) | not reported | [3.7](/filings/0001213900-24-097455.md) | [3.0](/filings/0001213900-25-014437.md) | [2.9](/filings/0001213900-26-078693.md) | [2.6](/filings/0001213900-25-076590.md) | [2.4](/filings/0001213900-25-110391.md) | [2.3](/filings/0001213900-26-016885.md) | [2.5](/filings/0001213900-26-089946.md) | [2.1](/filings/0001213900-26-089946.md) |
| Shareholders' equity | $m | [(287)](/filings/0001213900-24-097455.md) | [(26.2)](/filings/0001213900-24-014163.md) | [(33.7)](/filings/0001213900-26-078693.md) | [(31.5)](/filings/0001213900-26-016885.md) | [(32.8)](/filings/0001213900-26-016885.md) | [(38.4)](/filings/0001213900-26-016885.md) | [(25.3)](/filings/0001213900-26-089946.md) | [(26.8)](/filings/0001213900-26-089946.md) | [(27.7)](/filings/0001213900-26-016885.md) | [(27.4)](/filings/0001213900-26-016885.md) | [(35.3)](/filings/0001213900-26-089946.md) | [(35.7)](/filings/0001213900-26-089946.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.8) d](/filings/0001213900-24-097455.md) | [1.7 d](/filings/0001213900-25-014437.md) | [(13.7) d](/filings/0001213900-25-059675.md) | [(1.8)](/filings/0001213900-25-076590.md) | [(0.7) d](/filings/0001213900-25-110391.md) | [(2.5) d](/filings/0001213900-26-016885.md) | [(3.5) d](/filings/0001213900-26-078693.md) | [0.2](/filings/0001213900-26-089946.md) | [(0.7) d](/filings/0001213900-25-110391.md) | [(0.8) d](/filings/0001213900-26-016885.md) | [(0.1) d](/filings/0001213900-26-078693.md) | [(0.5)](/filings/0001213900-26-089946.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001213900-26-089946.md) | [(0.0) d](/filings/0001213900-25-110391.md) | [0.0 d](/filings/0001213900-26-016885.md) | [0.0 d](/filings/0001213900-26-078693.md) | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2021-09-30) | Q4 FY2022 (2022-12-31) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [7.0](/filings/0001410578-21-000515.md) | [0.5](/filings/0001213900-24-014163.md) | [0.0](/filings/0001213900-24-097455.md) | [0.2](/filings/0001213900-25-014437.md) | [0.0](/filings/0001213900-25-076590.md) | [0.0](/filings/0001213900-25-110391.md) | [0.1](/filings/0001213900-26-016885.md) | [8.5](/filings/0001213900-25-076590.md) | [11.8](/filings/0001213900-25-110391.md) | [12.2](/filings/0001213900-26-016885.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,770,836 at 2026-08-13, from the cover of the [10-Q filed 2026-08-14](/filings/0001213900-26-089946.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.